Skip to main content

Table 3 Multivariate logistic regression analysis for the moderate or high disease activity in rheumatoid arthritis patients

From: The association between comorbidities and disease activity in patients with rheumatoid arthritis: a multicenter, cross-sectional cohort study in Japan with the highest proportion of elderly individuals

Variables

OR

95%CI

p value

Age

1.0005

0.9923–1.0183

0.4303

Female

1.7759

1.1951–2.6826

0.0054*

Disease duration

0.9979

0.9965–0.9993

0.0041*

Steinbrocker stage

1.1723

0.9972–1.3786

0.0540

Steinbrocker class

2.4559

1.9617–3.0942

<0.0001*

ACPA

1.0008

1.0001–1.0016

0.0211*

MTX usage

1.0330

0.7607–1.4072

0.8356

PSL usage

1.8142

1.3524–2.4352

<0.0001*

Biologics/JAK usage

0.4870

0.3431–0.6849

<0.0001*

Hypertension

1.0769

0.7698–1.5013

0.6632

Diabetes mellitus

1.2927

0.7782–2.1835

0.3182

Respiratory disease

1.4247

0.9261–2.1846

0.1053

Cerebrovascular disease

1.8682

1.0642–3.6347

0.0334*

Cardiovascular disease

1.5137

0.8919–2.5645

0.1229

Renal disease

1.1947

0.8229–1.7320

0.3479

Malignant tumor

0.7047

0.3762–1.2753

0.2590

  1. OR odds ratio, CI confidence interval, ACPA anticyclic citrullinated peptide antibody, MTX methotrexate, PSL prednisolone, JAK Janus kinase inhibitors
  2. *Statistically significant